Can anti-parasitic drugs help control COVID-19?-Reference-Cited by-同舟云学术

Can anti-parasitic drugs help control COVID-19?

Published:2022-05 Issue:5 Volume:17 Page:315-339
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Panahi Yasin¹^ORCID,Dadkhah Masoomeh²^ORCID,Talei Sahand³^ORCID,Gharari Zahra⁴^ORCID,Asghariazar Vahid⁵^ORCID,Abdolmaleki Arash⁶⁷^ORCID,Matin Somayeh⁸,Molaei Soheila²⁹^ORCID

Affiliation:

1. Department of Pharmacology & Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran

2. Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4. Department of Biotechnology, Faculty of Biological Sciences, Al-Zahra University, Tehran, Iran

5. Deputy of Research & Technology, Ardabil University of Medical Sciences, Ardabil, Iran

6. Department of Engineering Sciences, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Namin, Iran

7. Bio Science & Biotechnology Research center (BBRC), Sabalan University of Advanced Technologies (SUAT), Namin, Iran

8. Department of Internal Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran

9. Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Abstract

Novel COVID-19 is a public health emergency that poses a serious threat to people worldwide. Given the virus spreading so quickly, novel antiviral medications are desperately needed. Repurposing existing drugs is the first strategy. Anti-parasitic drugs were among the first to be considered as a potential treatment option for this disease. Even though many papers have discussed the efficacy of various anti-parasitic drugs in treating COVID-19 separately, so far, no single study comprehensively discussed these drugs. This study reviews some anti-parasitic recommended drugs to treat COVID-19, in terms of function and in vitro as well as clinical results. Finally, we briefly review the advanced techniques, such as artificial intelligence, that have been used to find effective drugs for the treatment of COVID-19.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2021-0160

Reference225 articles.

1. WHO. COVID-19: One year later – WHO Director-General’s new year message. http://www.who.int/News/Item/30-12-2020-COVID-19-Anniversary-and-Looking-Forward-to-2021

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3. A novel electrochemical sensing platform for detection of dopamine based on gold nanobipyramid/multi-walled carbon nanotube hybrids

4. Severe Acute Respiratory Syndrome

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring COVID-19 Pandemic Disparities with Transcriptomic Meta-analysis from the Perspective of Personalized Medicine;Journal of Microbiology;2024-07-09

2. Effect of niclosamide on colorectal cancer induced by dimethylhydrazine in albino mice;Egyptian Journal of Basic and Applied Sciences;2023-12-04

3. Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients;Pharmaceuticals;2023-05-29

4. A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease?;Future Virology;2023-02

5. Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches;Chemico-Biological Interactions;2022-11